Next-generation CAR-T lymphocytes helped glioblastoma in pilot trial
U.S. researchers have presented preliminary results from the first phase I clinical trial of CARv3-T lymphocytes injected into the ventricles of the brain to treat recurrent glioblastoma
19.03.2024